Merck & Co Inc. (MRK) on Tuesday said HERTHENA-Lung02 phase 3 study evaluating Daiichi Sankyo and Merck's patritumab deruxtecan in ...

Merck & Co., Inc. (MRK) and Daiichi Sankyo (DSKYF.PK) announced that an interim analysis of the dose-optimization phase of the ...

(RTTNews) - Merck & Co., Inc. (MRK) and Daiichi Sankyo (DSKYF.PK) announced that an interim analysis of the dose-optimization phase of the ongoing IDeate-Lung01 Phase 2 trial shows ifinatamab ...

Data at WCLC and ESMO showcasing Daiichi Sankyo’s progress towards its goal of creating new standards of care for patients with cancer will include six late-breaking presentations, including two ...

MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care ...

Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute, Genentech, Vertex, ICON, Halfloop, and Pfizer; and has a family member who owns shares in GSK. RC receives funding ...

2,3 Patient comorbidities and frailty may unnecessarily affect CVD management. 4,5,6 Daiichi Sankyo remains committed to its promise to continue expanding medical knowledge to support better CV ...

As of the writing, there is no official statement from Facebook regarding the reason for changing the icon to black and blue. However, it may be related to the upcoming full release of iOS 18 on ...

Duolingo, the language-learning platform, has been receiving a wave of criticism since the release of its new app icon that looks 'sick.' The original Duo logo is typically depicted with a calm ...

Is your Facebook icon looking a little dreary? Users have taken to social media to comment on the "new" appearance of the app shortcut on their phones. It now is appearing as a black background ...

global head of research and development at Daiichi Sankyo, in a press release. Brexucabtagene autoleucel (Tecartus; brexu-cel) is confirmed as an effective treatment for patients with ...